dacarbazine has been researched along with Acromegaly Due To Pituitary Adenoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jouanneau, E; Raverot, G; Trouillas, J | 1 |
| Amirbaigloo, A; Cusimano, MD; Di Ieva, A; Fathalla, H; Ghazi, AA; Kovacs, K; Rotondo, F; Syro, LV | 1 |
2 review(s) available for dacarbazine and Acromegaly Due To Pituitary Adenoma
| Article | Year |
|---|---|
Management of endocrine disease: clinicopathological classification and molecular markers of pituitary tumours for personalized therapeutic strategies.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Dacarbazine; Follicle Stimulating Hormone; Growth Hormone-Secreting Pituitary Adenoma; Human Growth Hormone; Humans; Luteinizing Hormone; Pituitary Hormones, Anterior; Pituitary Neoplasms; Prognosis; Prolactin; Prolactinoma; Temozolomide; Thyrotropin | 2014 |
Treatment of invasive silent somatotroph pituitary adenoma with temozolomide. Report of a case and review of the literature.
Topics: Adenoma; Adult; Antineoplastic Agents, Alkylating; Asymptomatic Diseases; Dacarbazine; Growth Hormone-Secreting Pituitary Adenoma; Humans; Male; Neoplasm Invasiveness; Temozolomide | 2015 |